Stage II Enteropathy-Associated T-Cell Lymphoma

Explore clinical trials studying Stage II Enteropathy-Associated T-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Stage II Enteropathy-Associated T-Cell Lymphoma trial results

Completed

NCT02561273

Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Enteropathy-Associated T-Cell Lymphoma, +21 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

Stanford Cancer Institute Palo Alto, California, United States

University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora, Colorado, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States